Psoriasis adverse events and associated medications as reported in the US Food and Drug Reporting System from 2016 to 2021

被引：1

作者：

Learned, Christine ^{[1
]}

Alsukait, Sara ^{[1
]}

Deverapalli, Sandhya ^{[1
]}

Elliott, Erika ^{[1
]}

Moody, Katherine ^{[1
]}

Sobell, Jeffrey ^{[1
]}

Konnikov, Nellie ^{[2
]}

Ortega, Melissa ^{[3
]}

Rosmarin, David ^{[1
]}

机构：

[1] Tufts Med Ctr, Dept Dermatol, 800 Washington Str, Boston, MA 02111 USA

[2] Boston VA Med Ctr, Dept Dermatol, Boston, MA USA

[3] Tufts Med Ctr, Dept Pharm, Boston, MA USA

来源：

JAAD INTERNATIONAL | 2022年 / 7卷

关键词：

adverse events; drug reactions; drug-induced psoriasis; immunodermatology; psoriasis;

D O I：

10.1016/j.jdin.2022.03.010

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：144 / 145

页数：2

共 50 条

[1] Vitiligo adverse events and associated medications as reported in the US Food and Drug Administration's Adverse Event Reporting System from 2016 to 2021
Learned, Christine
Cohen, Stephanie R.
Alsukait, Sarah
Deverapalli, Sandhya
Rosmarin, David
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (01) : 197 - 199
[2] Adverse events reported to the US Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel
Dores, Graca M.
Jason, Christopher
Niu, Manette T.
Perez-Vilar, Silvia
AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (09) : 1087 - 1100
[3] Reported Adverse Events with Painkillers: Data Mining of the US Food and Drug Administration Adverse Events Reporting System
Jae Min
Vicki Osborne
Allison Kowalski
Mattia Prosperi
Drug Safety, 2018, 41 : 313 - 320
[4] Reported Adverse Events with Painkillers: Data Mining of the US Food and Drug Administration Adverse Events Reporting System
Min, Jae
Osborne, Vicki
Kowalski, Allison
Prosperi, Mattia
DRUG SAFETY, 2018, 41 (03) : 313 - 320
[5] Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019
Shaokui Wei
Manette T. Niu
Graça M. Dores
Drugs - Real World Outcomes, 2021, 8 : 253 - 262
[6] Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986-2019
Wei, Shaokui
Niu, Manette T.
Dores, Graca M.
DRUGS-REAL WORLD OUTCOMES, 2021, 8 (02) : 253 - 262
[7] The Top Reported Medications Associated with Life-Threatening Adverse Drug Events in Saudi Arabia: Insights from a Spontaneous Reporting System
Alblowi, Fotoun
Alharbi, Muhanad
Aldajani, Alhanouf
DRUG SAFETY, 2024, 47 (12) : 1386 - 1387
[8] A retrospective analysis of medications associated with pityriasis rosea reported in the FDA adverse events reporting system
Mashoudy, Kayla D.
Ye-Tay, Joselyn
Nouri, Keyvan
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
[9] Adverse events associated with herbal medicine products reported in the Korea Adverse Event Reporting System from 2012 to 2021
Choi, Yujin
Shin, Hyeun-Kyoo
FRONTIERS IN PHARMACOLOGY, 2024, 15
[10] Reporting Cosmetic Adverse Events to the US Food and Drug Administration
Katz, Linda M.
Valenzuela, Claudia
Sadrieh, Nakissa K.
DERMATITIS, 2016, 27 (04) : 236 - 237

← 1 2 3 4 5 →